Neurophet AQUA AD Plus
Save to shortlistLast reviewed Oct 31, 2026 against the sources listed on this page · How we review
At a glance
Neurophet AQUA AD Plus is AI brain MRI analysis software that segments and measures brain regions and atrophy to support evaluation of Alzheimer's disease, including monitoring for ARIA in…
- FDA:
- 510(k) K252496
- Epic:
- Not on record
- Named users:
- 1 named in public reports
- Published study:
- Not on record
Description
Neurophet AQUA AD Plus is AI brain MRI analysis software that segments and measures brain regions and atrophy to support evaluation of Alzheimer's disease, including monitoring for ARIA in patients on anti-amyloid therapy. FDA 510(k) K252496, cleared January 2026.
Quick answers
Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review
- Is Neurophet AQUA AD Plus FDA cleared?
- The public FDA database has one record that our team matched to Neurophet AQUA AD Plus. The most recent is 510(k) K252496 (Neurophet AQUA AD Plus), decided Jan 2026. Check that the cleared use matches how you plan to use it.FDA record K252496
- Which health systems use Neurophet AQUA AD Plus?
- Linked public reports name one organization: Raffles Medical. "Who's using this" below lists them all, plus any the maker reports. Ask the vendor for a reference at an organization like yours.Raffles Medical (Korea Biomedical Review)
Security & contracting
The maker has not reported these details yet. Ask the vendor directly during evaluation.
- Workflow stage
- Not reported
- Integrations
- Not reported
- Data inputs
- Not reported
- Deployment
- Not reported
- Signs a BAA
- Not reported
- SOC 2 report
- Not reported
- HITRUST
- Not reported
- Evidence type
- Regulatory submission summary
Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.
Who's using this
1 organizationOrganizations named in public announcements or by the developer. Inclusion is not an endorsement.
Last checked Oct 31, 2026. Spot an error? Let us know through the discussion below.
Get weekly updates for Neurology
Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.
Sources
This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.
Website FDA RecordFDA database records
- K252496 · 510(k) · Jan 2026Neurophet AQUA AD Plus
Matched by our team from the public FDA database; checked Nov 10, 2026.
Developer
Neurophet
Evaluating this tool?
Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.
Prepare evaluation packetChecklist for your role: Admin · Physician · IT · Compliance
Compare similar tools →